Intranasal mucoadhesive buspirone formulation: In vitro characterization and nasal clearance studies

Pharmazie

Volumn 63, Issue 5, 2008, Pages 348-351

  Khan, Shagufta A ^a   Patil, K S ^a   Yeole, P G ^a  

^a INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BUSPIRONE; CHITOSAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG CLEARANCE; DRUG FORMULATION; DRUG PENETRATION; DRUG RETENTION; NONHUMAN; RADIOACTIVITY; RAT;

ADHESIVES; ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-ANXIETY AGENTS; BENZALKONIUM COMPOUNDS; BUSPIRONE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; FEMALE; FIBROBLASTS; HALF-LIFE; MALE; MICE; NASAL MUCOSA; PERMEABILITY; PRESERVATIVES, PHARMACEUTICAL; RATS; SWINE;

EID: 44349115475     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7341     Document Type: Article

References (17)

1. Ahuja A, Khar RK, Ali J (1997) Mucoadhesive drug delivery systems. Drug Del Ind Pharm 23: 489-515.
2. 2). Pharm Res 11: 1358-1361.
3. Birudaraj R, Berner B, Shen S, Li X (2005) Buccal permeation of buspirone: mechanistic studies on transport pathway. J Pharm Sci 9: 70-78.
4. Borchard G, Luessen HL, deBoer AG, Verhoef JC, Lehr CM, Junginger HE (1996) The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J Control Rel 39: 131-138.
5. Dodane V, Khan MA, Merwin JR (1999) Effect of chitosan on epithelial permeability and structure. Int J Pharm 182: 21-32.
6. rd ed, vol II, Pharmaceutical Press, UK, p 726-727.
7. Harris D, Robinson JR (1990) Bioadhesive polymers in peptide drug delivery. Biomaterials 11: 652-658.
8. Illum L (1998) Bioadhesive Formulations for Nasal Peptide Delivery. In: Frokjaer S, Christrup L and Krogsgaard LP (eds), Bioadhesion in Drug Delivery. Munksgaard Copenhagen, p 157-170.
9. Illum L, Jorgensen H, Bisgaard H, Krogsgaard O, Rossing N (1987) Bioadhesive microspheres as a potential nasal drug delivery system. Int J Pharm, 39: 189-199.
10. Illum L, Watts P, Fisher AN, Jabbal-gill, I, Davis SS (2000) Novel chitosan-based delivery system for the nasal administration of a LHRH-analogue. STP Pharm Sci 10: 89-91.
11. Leung SHS and Robinson JR (1988) The contribution of anionic polymer structural features to mucoadhesion. J Control Rel 5: 223-231.
12. Maitani Y, Asano S, Takahashi S, Nakagaki M, Nagai T (1992) Permeability of insulin entrapped in liposomes through the nasal mucosa of rabbits. Chem Pharm Bull, 40: 1569-1572.
13. Mao S, Chen J, Wei Z, Li H, Bi D (2004) Intranasal administration of melatonin starch microspheres. Int J Pharm 272: 37-43.
14. Mortazavi SA and Smart JD (1994) An in vitro method for assessing the duration of mucoadhesion. J Control Rel 31: 207-21.
15. Nakamuru F, Ohta R, Machid X, Naga T (1996) In vitro and in vivo nasal mucoadhesion of some water soluble polymers. Int J Pharm 134: 173-181.
16. Schipper NGM, Olssom S, Hoogstraate JA, De boer AG, Varum KM, Artursson P (1997) Chitosan as absorption enhancers for poorly absorbable drugs. 2: Mechanism of absorption enhancement. Pharm Res 14: 923-929.
17. Wadell C, Bjork E, Camber O (1999) Nasal drug delivery-evaluation of an in vitro model using porcine nasal mucosa. Eur J Pharm Sci 7: 197-206.